RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

The lack of a letter may indicate that this thing isn't as dead as we think it is. There is just no way that the FDA can shut down a promising compound whose efficacy has been shown, and whose safety profile has been exhaustively tested without a written explanation of why they decided to kill it. The FOIA was set up precisely for cases like this, and the notion that we should worry about the FDA getting pissed-off is laughable. It's not COR that is demanding a letter it is shareholders. Why should the FDA take it out on COR?